BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//HKAPI - ECPv5.3.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HKAPI
X-ORIGINAL-URL:https://www.hkapi.hk/zh/
X-WR-CALDESC:Events for HKAPI
BEGIN:VTIMEZONE
TZID:Asia/Hong_Kong
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:HKT
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Asia/Hong_Kong:20220311T140000
DTEND;TZID=Asia/Hong_Kong:20220311T163000
DTSTAMP:20260407T213749
CREATED:20220208T081801Z
LAST-MODIFIED:20220301T084343Z
UID:11700-1647007200-1647016200@www.hkapi.hk
SUMMARY:HKAPI Regulatory Training Workshop Series - Seminar 3
DESCRIPTION:HKAPI Regulatory Training Workshop Series- Seminar 3\nDate: 11 March 2022 (Fri) \nTime: 2:00 pm – 4:30 pm \nRSVP: Please contact the HKAPI Office \nFee: To be confirmed \n\nContent\n\n\n\nTime\nTopic\nSpeaker\n\n\n2:00 pm – 2:20 pm\nGlobal Trend of e-labeling: and case sharing \nDr. Sara Ellmark  \nExecutive Regulatory Science Director \nAstrazeneca\n\n\n2:20 pm – 2:30pm\nQ&A\nMs. Susanna Yim (Moderator)  \nAssociate Director Regulatory Affairs at Janssen Pharmaceutical Companies of Johnson & Johnson / Sub-team Lead of HKAPI Regulatory Affairs\n\n\n2:30 pm – 3:05 pm\nUpdates on CORP Registration\nMr. Albert Chung \nPharmacist \nDrug Office \nDepartment of Health\n\n\n3:05 pm – 3:20 pm\nQ&A\nMs. Susanna Yim (Moderator)  \nAssociate Director Regulatory Affairs at Janssen Pharmaceutical Companies of Johnson & Johnson / Sub-team Lead of HKAPI Regulatory Affairs\n\n\n3:20 pm – 3:25 pm\nBreak\n \n\n\n3:25 pm – 4:30 pm\nWorkshop on CORP Registration: \nExercises to enhance submission standard and learn from best practice\nEducation Sub-team of HKAPI Regulatory Affairs \n\n\n\n  \n\nAbout the Speaker \nDr. Sara ELLMARK \nExecutive Regulatory Science Director\, AstraZeneca Sweden \nPhD\, Molecular Biology\, Gothenburg University\, Sweden \nSara has 15+ years’ experience in pharmaceutical development in various roles across medical communications\, regulatory affairs and global labelling. \nHer current role is Executive Regulatory Science Director in AstraZeneca\, and previously she led AstraZeneca’s Global Labelling Group. Sara has also been actively engaged in e-labelling related activities\, both within AstraZeneca and as an active member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) ePI working group\, as well as the Inter-Association Task Force (IATF) for e-labelling.
URL:https://www.hkapi.hk/zh/event/hkapi-regulatory-training-workshop-series-seminar-3/
LOCATION:Virtual Meeting
CATEGORIES:Member's only,Regulatory
ATTACH;FMTTYPE=image/jpeg:https://www.hkapi.hk/wp-content/uploads/2022/02/Blue-and-Red-72x36-Landscape-Voter-Education-Campaign-Banner-1-min-scaled.jpg
END:VEVENT
END:VCALENDAR